脳卒中の栄養療法

出版社： 羊土社
著者：
発行日： 2020-03-05
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784758118651
電子書籍版： 2020-03-05 （第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,180 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,180 円(税込)

購入する

商品紹介

超急性期の栄養管理や製剤選択から回復期・維持期のリハビリテーションまで，脳卒中治療に必要な栄養療法についての解説を1冊に集約．脳卒中治療に関わる医師・メディカルスタッフ必携のこれまでなかった実践書！

目次

  • 第１章　栄養療法の基本
    　1．脳卒中診療における栄養療法の重要性
    　2．栄養管理の基礎知識
    　3．腸管の役割
    　4．脳卒中栄養療法におけるナーシングケア

    第２章　脳卒中急性期の栄養管理の実践
    　1．脳卒中急性期における栄養療法の考え方
    　2．脳卒中患者における製剤選択の注意点
    　3．重症度別の栄養管理
    　4．嚥下機能とリハビリテーション
    　5．併発症・合併症と栄養管理
    　6．こんなとき，どうする？
    　　　Q1　経腸栄養を開始したら，下痢になってしまいました．
    　　　　　　どのように対応したらよいでしょうか？
    　　　Q2　経腸栄養投与後，嘔吐してしまいました．
    　　　　　　どのように対応するのがよいでしょうか？
    　　　Q3　経管経腸栄養を開始しましたが，目標投与量を投与できません．
    　　　　　　静脈栄養を併用したいのですがどのようなことに気をつけたらよいでしょうか？
    　　　Q4　絶食が続いた後に経腸栄養を始める場合の注意点はありますか？
    　　　Q5　急性期治療後，血清アルブミン値（Alb）が急激に低下しました．
    　　　　　　どう対応するのがよいでしょうか？
    　　　Q6　胃瘻造設を家族に拒否されました．どのように対応しますか？

    第３章　脳卒中回復期・維持期の栄養療法
    　1．脳卒中回復期の栄養管理
    　2．脳卒中後嚥下障害に対する嚥下機能訓練
    　3．フレイル/サルコペニアへの対応と対策
    　4．回復期から維持期への移行期における栄養管理
    　5．こんなとき，どうする？
    　　　Q1　リハビリテーションに伴い活動量が増加した場合の栄養管理のポイントは？
    　　　Q2　食思不振がみられた場合はどのように対応したらよいか？
    　　　Q3　嚥下調整食が必要な方が自宅退院する場合に注意すべきポイントは？
    　　　Q4　自宅に経腸栄養剤を宅配してほしいときはどうすればよいか？

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 栄養療法の基本

P.17 掲載の参考文献
1) 「脳卒中治療ガイドライン 2015」(日本脳卒中学会 脳卒中ガイドライン委員会), 協和企画, 2015
 
2) Dennis MS, et al:Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD):a multicentre randomised controlled trial. Lancet, 365:764-772, 2005
PubMed
3) Dennis M, et al:FOOD:a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. Health Technol Assess, 10:iii-iv, ix, 2006
 
4) Dhaliwal R, et al:The Canadian critical care nutrition guidelines in 2013:an update on current recommendations and implementation strategies. Nutr Clin Pract, 29:29-43, 2014
PubMed
5) McClave SA, et al:Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr, 40:159-211, 2016
 
6) Kreymann KG, et al:ESPEN Guidelines on Enteral Nutrition:Intensive care. Clin Nutr, 25:210-223, 2006
PubMed
7) Doig GS, et al:Early enteral nutrition reduces mortality in trauma patients requiring intensive care:a meta-analysis of randomised controlled trials. Injury, 42:50-56, 2011
PubMed
8) Fearon KC, et al:Enhanced recovery after surgery:a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr, 24:466-477, 2005
PubMed
9) Weimann A, et al:ESPEN guideline:Clinical nutrition in surgery. Clin Nutr, 36:623-650, 2017
 
10) Burgos R, et al:ESPEN guideline clinical nutrition in neurology. Clin Nutr, 37:354-396, 2018
PubMed
11) 西岡心大, 他:本邦回復期リハビリテーション病棟入棟患者における栄養障害の実態と高齢脳卒中患者における転帰, ADL帰結との関連. 日静脈経腸栄会誌, 30:1145-1151, 2015
 
12) FOOD Trial Collaboration:Poor nutritional status on admission predicts poor outcomes after stroke:observational data from the FOOD trial. Stroke, 34:1450-1456, 2003
PubMed
13) Gariballa SE, et al:Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr, 68:275-281, 1998
PubMed
14) 吉村芳弘:回復期のリハビリテーション栄養管理. 日静脈経腸栄会誌, 31:959-966, 2016
 
15) Nishioka S, et al:Malnutrition risk predicts recovery of full oral intake among older adult stroke patients undergoing enteral nutrition:Secondary analysis of a multicentre survey (the APPLE study). Clin Nutr, 36:1089-1096, 2017
PubMed
16) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン. 日集中医誌, 23:185-281, 2016
 
17) 寺島秀夫:侵襲下の内因性エネルギー供給を考慮した理論的エネルギー投与法の提言. Intensivist, 3:423-433, 2011
 
18) 寺島秀夫:過剰栄養投与の有害性とモニタリング:重症患者の栄養療法はoverfeedingの正しい理解から始まる. Intensivist, 11:327-333, 2019
 
19) 日本摂食嚥下リハビリテーション学会 医療検討委員会:間歇的口腔食道経管栄養法の標準的手順. 日摂食嚥下リハ会誌, 19:234-238, 2015
 
P.36 掲載の参考文献
1) Khalid I, et al:Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am J Crit Care, 19:261-268, 2010
 
2) Doig GS, et al:Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients:a meta-analysis of randomised controlled trials. Intensive Care Med, 35:2018-2027, 2009
PubMed
3) Doig GS, et al:Early enteral nutrition in critical illness:a full economic analysis using US costs. Clinicoecon Outcomes Res, 5:429-436, 2013
PubMed
4) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン. 日集中医誌, 23:185-281, 2016
 
5) Simpson F & Doig GS:Parenteral vs. enteral nutrition in the critically ill patient:a meta-analysis of trials using the intention to treat principle. Intensive Care Med, 31:12-23, 2005
 
6) Iovinelli G, et al:Nutrition support after total laryngectomy. JPEN J Parenter Enteral Nutr, 17:445-448, 1993
PubMed
7) Peter JV, et al:A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med, 33:213-220;discussion 260, 2005
 
8) Berg RD & Garlington AW:Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun, 23:403-411, 1979
 
9) Doig GS, et al:Early enteral nutrition reduces mortality in trauma patients requiring intensive care:a meta-analysis of randomised controlled trials. Injury, 42:50-56, 2011
PubMed
10) Khalid I, et al:Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am J Crit Care, 19:261-268, 2010
 
11) Mancl EE & Muzevich KM:Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy. JPEN J Parenter Enteral Nutr, 37:641-651, 2013
PubMed
12) Rai SS, et al:Enteral nutrition for patients in septic shock:a retrospective cohort study. Crit Care Resusc, 12:177-181, 2010
PubMed
13) Berger MM, et al:Enteral nutrition in critically ill patients with severe hemodynamic failure after cardiopulmonary bypass. Clin Nutr, 24:124-132, 2005
PubMed
14) Berger MM, et al:Intestinal absorption in patients after cardiac surgery. Crit Care Med, 28:2217-2223, 2000
PubMed
15) Lopez-Herce J, et al:Risk factors for gastrointestinal complications in critically ill children with transpyloric enteral nutrition. Eur J Clin Nutr, 62:395-400, 2008
PubMed
16) Shang E, et al:Pump-assisted versus gravity-controlled enteral nutrition in long-term percutaneous endoscopic gastrostomy patients:a prospective controlled trial. JPEN J Parenter Enteral Nutr, 27:216-219, 2003
PubMed
17) 宮澤靖:経腸栄養(EN)コトはじめ. レジデントノート, 20:2037-2048, 2018
Medical*Online
18) Martinez Augustin O & Martinez de Victoria Munoz E:Proteins and peptides in enteral nutrition. Nutr Hosp, 21 Suppl 2:1-13, 1, 2006
 
19) 鈴木平光, 他:EPA及びDHAの代謝と機能. 油化学, 37:781-787, 1988
 
20) Kruse LG & Ogletree RL Jr:Omega-3 fatty acids and cardiovascular risk. J Miss State Med Assoc, 54:156-157, 2013
PubMed
21) Meier R & Gassull MA:Consensus recommendation on the effects and benefits of fiber in critical practice. Clin Nutr Suppl, 1:73-80, 2004
 
22) Rushdi TA, et al:Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition:a prospective randomized controlled trial. Clin Nutr, 23:1344-1352, 2004
PubMed
23) 大石英人:REF-P1(粘度調整食品)による経腸栄養剤の安全な小腸半固形化導入法について. 経腸栄養の最新トピック, 15:1-4, 2014
 
24) ASPEN Board of Directors and the Clinical Guidelines Task Force:Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr, 26:1SA-138SA, 2002
PubMed
25) 「静脈経腸栄養ガイドライン 第3版」(日本静脈経腸栄養学会/編), pp2-176, 照林社, 2013
 
26) 「コメディカルのための静脈・経腸栄養手技マニュアル」(日本静脈経腸栄養学会/編), pp55-133, 南江堂, 2004
 
27) Stratton RJ & Elia M:Encouraging appropriate, evidence-based use of oral nutritional supplements. Proc Nutr Soc, 69:477-487, 2010
PubMed
28) Gariballa S, et al:A randomized, double-blind, placebo-controlled trial of nutritional supplementation during acute illness. Am J Med, 119:693-699, 2006
PubMed
29) Norman K, et al:Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease--a randomized controlled trial. Clin Nutr, 27:48-56, 2008
PubMed
30) Stratton RJ, et al:A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev, 12:884-897, 2013
PubMed
31) Norman K, et al:Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition:a randomised controlled pilot study. Eur J Clin Nutr, 65:735-742, 2011
PubMed
P.44 掲載の参考文献
1) Stower H:Depression linked to the microbiome. Nat Med, 25:358, 2019
 
2) Miyake S, et al:Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One, 10:e0137429, 2015
PubMed
3) Hasegawa S, et al:Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease. PLoS One, 10:e0142164, 2015
PubMed
4) Nagashima K, et al:Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol, 69:1251-1262, 2003
PubMed
5) Saji N, et al:Analysis of the relationship between the gut microbiome and dementia:a cross-sectional study conducted in Japan. Sci Rep, 9:1008, 2019
PubMed
6) Arumugam M, et al:Enterotypes of the human gut microbiome. Nature, 473:174-180, 2011
PubMed
7) Saji N, et al:The relationship between the gut microbiome and mild cognitive impairment in patients without dementia:a cross-sectional study conducted in Japan. Sci Rep, 9:19227, 2019 doi:10.1038/s41598-019-55851-y
 
8) Saji N, et al:Proportional changes in the gut microbiome:a risk factor for cardiovascular disease and dementia? Hypertens Res, 42:1090-1091, 2019
PubMed
P.65 掲載の参考文献
1) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン. 日集中医誌, 23:185-281, 2016
 
2) Hiebert JM, et al:Comparison of continuous vs intermittent tube feedings in adult burn patients. JPEN J Parenter Enteral Nutr, 5:73-75, 1981
PubMed
3) Drakulovic MB, et al:Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients:a randomised trial. Lancet, 354:1851-1858, 1999
PubMed
4) Metheny NA, et al:Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients:frequency, outcomes, and risk factors. Crit Care Med, 34:1007-1015, 2006
PubMed
5) Ciocon JO, et al:Continuous compared with intermittent tube feeding in the elderly. JPEN J Parenter Enteral Nutr, 16:525-528, 1992
PubMed
6) Shang E, et al:Pump-assisted enteral nutrition can prevent aspiration in bedridden percutaneous endoscopic gastrostomy patients. JPEN J Parenter Enteral Nutr, 28:180-183, 2004
PubMed
7) 金憲経, 他:地域高齢者におけるサルコペニア改善のための運動, アミノ酸補充の効果. アミノ酸研究, 4:55-57, 2010
 
8) Demling RH:Nutrition, anabolism, and the wound healing process:an overview. Eplasty, 9:e9, 2009
PubMed
9) Cereda E, et al:Efficacy of a Disease-Specific Nutritional Support for Pressure Ulcer Healing:A Systematic Review and Meta-Analysis. J Nutr Health Aging, 21:655-661, 2017
PubMed
10) Ohura T, et al:Evaluation of effects of nutrition intervention on healing of pressure ulcers and nutritional states (randomized controlled trial). Wound Repair Regen, 19:330-336, 2011
 

第2章 脳卒中急性期の栄養管理の実践

P.81 掲載の参考文献
1) Peter JV, et al:A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med, 33:213-220;discussion 260, 2005
 
2) McClave SA, et al:Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr, 40:159-211, 2016
 
3) Maeda K, et al:Tentative nil per os leads to poor outcomes in older adults with aspiration pneumonia. Clin Nutr, 35:1147-1152, 2016
PubMed
4) 「脳卒中治療ガイドライン 2015」(日本脳卒中学会 脳卒中ガイドライン委員会), 協和企画, 2015
 
5) 馬場重樹, 他:腸内細菌叢とdysbiosis. 日静脈経腸栄会誌, 33:1099-1104, 2018
 
6) 清水健太郎, 他:侵襲期における短鎖脂肪酸の重要性. 外科と代謝・栄養, 44:301-309, 2010
Medical*Online
7) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン. 日集中医誌, 23:185-281, 2016
 
8) 「治療が劇的にうまくいく!高齢者の栄養 はじめの一歩」(大村健二, 葛谷雅文/編), 羊土社, 2013
 
9) Urabe T, et al:Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients. Stroke, 40:1289-1295, 2009
PubMed
10) Kagansky N, et al:The role of hyperglycemia in acute stroke. Arch Neurol, 58:1209-1212, 2001
PubMed
11) Eslami S, et al:Glucose variability measures and their effect on mortality:a systematic review. Intensive Care Med, 37:583-593, 2011
PubMed
12) Okazaki T & Kuroda Y:Aneurysmal subarachnoid hemorrhage:intensive care for improving neurological outcome. J Intensive Care, 6:28, 2018
PubMed
13) Casaer MP, et al:Early versus late parenteral nutrition in critically ill adults. N Engl J Med, 365:506-517, 2011
PubMed
14) Rice TW, et al:Initial trophic vs full enteral feeding in patients with acute lung injury:the EDEN randomized trial. JAMA, 307:795-803, 2012
PubMed
15) 寺島秀夫:侵襲下の内因性エネルギー供給を考慮した理論的エネルギー投与法の提言. Intensivist, 3:423-433, 2011
 
16) Deutz NE, et al:Protein intake and exercise for optimal muscle function with aging:recommendations from the ESPEN Expert Group. Clin Nutr, 33:929-936, 2014
 
17) Weimann A, et al:ESPEN guideline:Clinical nutrition in surgery. Clin Nutr, 36:623-650, 2017
 
P.94 掲載の参考文献
1) Foley NC, et al:Which reported estimate of the prevalence of malnutrition after stroke is valid? Stroke, 40:e66-e74, 2009
PubMed
2) Friedli N, et al:Management and prevention of refeeding syndrome in medical inpatients:An evidence-based and consensus-supported algorithm. Nutrition, 47:13-20, 2018
PubMed
3) Oesch L, et al:Obesity paradox in stroke - Myth or reality? A systematic review. PLoS One, 12:e0171334, 2017
PubMed
4) 「脳卒中ガイドライン 2015[追補2019]」(日本脳卒中学会 脳卒中ガイドライン[追補2019]委員会/編), 協和企画, 2019
 
5) 「動脈硬化性疾患予防ガイドライン 2007年版」(日本動脈硬化学会/編), 日本動脈硬化学会, 2007 http://www.j-athero.org/publications/pdf/guideline_summary.pdf
 
6) 厚生労働省:日本人の食事摂取基準 2015年版 https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/syokuji_kijyun.html
 
7) Wang X, et al:Cholesterol levels and risk of hemorrhagic stroke:a systematic review and meta-analysis. Stroke, 44:1833-1839, 2013
PubMed
8) McKinney JS & Kostis WJ:Statin therapy and the risk of intracerebral hemorrhage:a meta-analysis of 31 randomized controlled trials. Stroke, 43:2149-2156, 2012
PubMed
9) Hackam DG, et al:Statins and intracerebral hemorrhage:collaborative systematic review and meta-analysis. Circulation, 124:2233-2242, 2011
PubMed
10) Preiss D, et al:Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy:a meta-analysis. JAMA, 305:2556-2564, 2011
PubMed
11) Takano T, et al:Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus. J Atheroscler Thromb, 13:95-100, 2006
PubMed
12) Mita T, et al:Preferable effect of pravastatin compared to atorvastatin on beta cell function in Japanese early-state type 2 diabetes with hypercholesterolemia. Endocr J, 54:441-447, 2007
PubMed
13) Yamazaki T, et al:Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (the J-PREDICT study):rationale, study design, and clinical characteristics of 1269 patients. Diabetol Int, 2:134-140, 2011
 
14) Odawara M, et al:(61-LB) Pitavastatin for the delay or prevention of diabetes development in individuals with impaired glucose tolerance. Late Breaking Abstracts (American Diabetes Association), 62(Suppl 1A):LB17, 2013 https://professional.diabetes.org/sites/professional.diabetes.org/files/media/combinedfile.pdf
 
15) Newman CB, et al:Statin Safety and Associated Adverse Events:A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol, 39:e38-e81, 2019
PubMed
16) Lynch JR, et al:Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage:results of a pilot randomized clinical trial. Stroke, 36:2024-2026, 2005
PubMed
17) Tseng MY, et al:Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage:a phase II randomized placebo-controlled trial. Stroke, 36:1627-1632, 2005
PubMed
18) Jauch EC, et al:Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44:870-947, 2013
PubMed
19) Ruff CT, et al:Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation:a meta-analysis of randomised trials. Lancet, 383:955-962, 2014
PubMed
20) de Groot NL, et al:Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users:development and validation of risk scores for either medication in two large Dutch cohorts. J Gastroenterol, 49:245-253, 2014
PubMed
21) Nakamura M, et al:Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction:J-AMI registry. Cardiovasc Interv Ther, 28:162-169, 2013
PubMed
22) Masclee GM, et al:Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology, 147:784-792.e9;quiz e13, 2014
 
23) Bhatt DL, et al:ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol, 52:1502-1517, 2008
 
24) Abraham NS, et al:ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation, 122:2619-2633, 2010
 
25) Hermansson M, et al:Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol, 9:25, 2009
PubMed
26) Sakurai Y, et al:Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study. Aliment Pharmacol Ther, 42:719-730, 2015
PubMed
27) Kawamura O, et al:Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring. Digestion, 91:19-25, 2015
 
28) Weijs PJ, et al:Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients. Crit Care, 18:701, 2014
PubMed
29) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン. 日集中医誌, 23:185-281, 2016
 
30) Herzig SJ, et al:Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA, 301:2120-2128, 2009
PubMed
31) Gomm W, et al:Association of Proton Pump Inhibitors With Risk of Dementia:A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol, 73:410-416, 2016
PubMed
32) Xie Y, et al:Risk of death among users of Proton Pump Inhibitors:a longitudinal observational cohort study of United States veterans. BMJ Open, 7:e015735, 2017
PubMed
33) Dyerberg J, et al:Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet, 2:117-119, 1978
PubMed
34) Yokoyama M, et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS):a randomised open-label, blinded endpoint analysis. Lancet, 369:1090-1098, 2007
PubMed
P.115 掲載の参考文献
1) McClave SA, et al:Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr, 40:159-211, 2016
 
2) Kreymann KG, et al:ESPEN Guidelines on Enteral Nutrition:Intensive care. Clin Nutr, 25:210-223, 2006
PubMed
3) Urabe T, et al:Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients. Stroke, 40:1289-1295, 2009
PubMed
4) 山本拓史, 他:非糖尿病患者における脳卒中急性期の経管経腸栄養の血糖値に及ぼす影響と低GI低GL製剤の効果について. 日静脈経腸栄会誌, 32:446, 2017
 
5) Tokunaga M, et al:Effect of Partially Hydrolyzed Guar Gum on Postprandial Hyperglycemia:A Randomized Double-blind, Placebo-controlled Crossover-study. 薬理と治療, 44:85-91, 2016
 
6) 日本カテキン学会:http://www.catechin-society.com/index.html
 
7) Matsui Y, et al:Effects of Tea Catechin-rich Beverage on Abdominal Fat Area and Body Weight in Obese Japanese Individuals:A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. 薬理と治療, 46:1383-1395, 2018
 
8) Casaer MP, et al:Early versus late parenteral nutrition in critically ill adults. N Engl J Med, 365:506-517, 2011
PubMed
9) 寺島秀夫, 米山智:Trophic feeding. 外科と代謝・栄養, 49:53-57, 2015
 
10) 寺島秀夫:侵襲下の内因性エネルギー供給を考慮した理論的エネルギー投与法の提言. Intensivist, 3:423-433, 2011
 
11) Rice TW, et al:Initial trophic vs full enteral feeding in patients with acute lung injury:the EDEN randomized trial. JAMA, 307:795-803, 2012
PubMed
12) Okazaki T, et al:Blood Glucose Variability:A Strong Independent Predictor of Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage. J Intensive Care Med, 33:189-195, 2018
 
13) van Donkelaar CE, et al:Early Circulating Lactate and Glucose Levels After Aneurysmal Subarachnoid Hemorrhage Correlate With Poor Outcome and Delayed Cerebral Ischemia:A Two-Center Cohort Study. Crit Care Med, 44:966-972, 2016
PubMed
14) de Aguilar-Nascimento JE, et al:Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke:a double-blind randomized trial. Nutrition, 27:440-444, 2011
PubMed
15) Perrone F, et al:Effects of preoperative feeding with a whey protein plus carbohydrate drink on the acute phase response and insulin resistance. A randomized trial. Nutr J, 10:66, 2011
PubMed
P.130 掲載の参考文献
1) Robbins J, et al:Swallowing after unilateral stroke of the cerebral cortex. Arch Phys Med Rehabil, 74:1295-1300, 1993
PubMed
2) Nagano A, et al:Rehabilitation Nutrition for Iatrogenic Sarcopenia and Sarcopenic Dysphagia. J Nutr Health Aging, 23:256-265, 2019
PubMed
3) Boulanger JM, et al:Canadian Stroke Best Practice Recommendations for Acute Stroke Management:Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018. Int J Stroke, 13:949-984, 2018
PubMed
4) Powers WJ, et al:2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 49:e46-e110, 2018
PubMed
5) 日本摂食嚥下リハビリテーション学会医療検討委員会:訓練法のまとめ (2014年版). 日摂食嚥下リハ会誌, 18:55-89, 2014
 
6) Obana M, et al:Effect of a collaborative transdisciplinary team approach on oral health status in acute stroke patients. J Oral Rehabil:doi:10.1111/joor.12855, 2019
 
7) 藤本篤士, 武井典子:口腔ケア概論. 「5 疾病の口腔ケア:チーム医療による全身疾患対応型口腔ケアのすすめ」(藤本篤士, 他/編著), pp8-10, 医歯薬出版, 2013
 
8) Nishioka S, et al:Impact of nutritional status, muscle mass and oral status on recovery of full oral intake among stroke patients receiving enteral nutrition:A retrospective cohort study. Nutr Diet:doi:10.1111/1747-0080.12579, 2019
 
9) Shiraishi A, et al:Impaired oral health status on admission is associated with poor clinical outcomes in post-acute inpatients:A prospective cohort study. Clin Nutr:doi:10.1016/j.clnu.2018.11.020, 2018
 
10) Andersson P, et al:Inter-rater reliability of an oral assessment guide for elderly patients residing in a rehabilitation ward. Spec Care Dentist, 22:181-186, 2002
 
11) 松尾浩一郎, 中川量晴:口腔ケアアセスメントシートOral Health Assessment Tool日本語版(OHAT-J)の作成と信頼性, 妥当性の検討. 障歯誌, 37:1-7, 2016
 
12) Gleeson K, et al:Quantitative aspiration during sleep in normal subjects. Chest, 111:1266-1272, 1997
PubMed
13) Bock JM, et al:Evaluation of the natural history of patients who aspirate. Laryngoscope, 127 Suppl 8:S1-S10, 2017
 
14) 「5分以内で助けよう! 誤嚥+窒息時のアプローチ」(井上登太/編著), pp88-89, gene, 2017
 
P.142 掲載の参考文献
1) Umpierrez GE, et al:Hyperglycemia:an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab, 87:978-982, 2002
PubMed
2) Clement S, et al:Management of diabetes and hyperglycemia in hospitals. Diabetes Care, 27:553-591, 2004
PubMed
3) Mizock BA:Alterations in carbohydrate metabolism during stress:a review of the literature. Am J Med, 98:75-84, 1995
 
4) Egi M, et al:Blood glucose concentration and outcome of critical illness:the impact of diabetes. Crit Care Med, 36:2249-2255, 2008
 
5) Finfer S, et al:Intensive versus conventional glucose control in critically ill patients. N Engl J Med, 360:1283-1297, 2009
PubMed
6) 「エビデンスに基づくCKD診療ガイドライン 2018」(日本腎臓学会/編), 東京医学社, 2018
 
7) Anderson JW, et al:Carbohydrate and fiber recommendations for individuals with diabetes:a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr, 23:5-17, 2004
PubMed
8) Schwingshackl L, et al:Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism:a systematic review and meta-analysis. Ann Nutr Metab, 58:290-296, 2011
PubMed
9) Egi M, et al:Blood glucose concentration and outcome of critical illness:the impact of diabetes. Crit Care Med, 36:2249-2255, 2008
 
10) Elia M, et al:Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes:a systematic review and meta-analysis. Diabetes Care, 28:2267-2279, 2005
PubMed
11) Aguilar MI, et al:Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology, 75:1343-1350, 2010
PubMed
12) Iseki K & Fukiyama K:Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant, 15:1808-1813, 2000
PubMed
13) D'Amico G, et al:Effect of dietary protein restriction on the progression of renal failure:a prospective randomized trial. Nephrol Dial Transplant, 9:1590-1594, 1994
PubMed
14) Niebauer J, et al:Endotoxin and immune activation in chronic heart failure:a prospective cohort study. Lancet, 353:1838-1842, 1999
PubMed
15) Poehlman ET, et al:Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med, 121:860-862, 1994
PubMed
16) Cruz-Jentoft AJ, et al:Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39:412-423, 2010
 
17) Fulster S, et al:Muscle wasting in patients with chronic heart failure:results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J, 34:512-519, 2013
PubMed
18) Evans WJ, et al:Cachexia:a new definition. Clin Nutr, 27:793-799, 2008
PubMed
19) Anker SD, et al:Wasting as independent risk factor for mortality in chronic heart failure. Lancet, 349:1050-1053, 1997
PubMed
20) 循環器病の診断と治療に関するガイドライン (2010年度合同研究報告):心筋梗塞二次予防に関するガイドライン (2011年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2011_ogawah_h.pdf (2019年10月閲覧)
 
21) Lichtenstein AH, et al:Diet and lifestyle recommendations revision 2006:a scientific statement from the American Heart Association Nutrition Committee. Circulation, 114:82-96, 2006
PubMed
22) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン, 日集中医誌, 23:185-281, 2016
 
23) Simpson F & Doig GS:Parenteral vs. enteral nutrition in the critically ill patient:a meta-analysis of trials using the intention to treat principle. Intensive Care Med, 31:12-23, 2005
 
24) Peter JV, et al:A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med, 33:213-20;discussion 260, 2005
 
25) Louie BE, et al:2004 MacLean-Mueller prize enteral or parenteral nutrition for severe pancreatitis:a randomized controlled trial and health technology assessment. Can J Surg, 48:298-306, 2005
PubMed
26) Thibault R, et al:Cardiogenic shock and nutrition:safe? Intensive Care Med, 37:35-45, 2011
PubMed
27) Casaer MP, et al:Early versus late parenteral nutrition in critically ill adults. N Engl J Med, 365:506-517, 2011
PubMed
28) Doig GS, et al:Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition:a randomized controlled trial. JAMA, 309:2130-2138, 2013
PubMed
29) Walker RN & Heuberger RA:Predictive equations for energy needs for the critically ill. Respir Care, 54:509-521, 2009
PubMed
30) Bauer J, et al:Evidence-based recommendations for optimal dietary protein intake in older people:a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc, 14:542-559, 2013
 
31) 日本循環器学会/日本心不全学会合同ガイドライン:急性・慢性心不全診療ガイドライン (2017年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf (2019年10月閲覧)
 
32) [Nutrition Support Dietetics Core Curriculum. 2nd ed] (Gottschlich MM, eds), A.S.P.E.N., 1993
 
33) Ponikowski P, et al:2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 18:891-975, 2016
 
P.146 掲載の参考文献
1) Lewis SJ & Heaton KW:Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol, 32:920-924, 1997
PubMed
2) Abbott:臨床栄養ハンドブック, 2014 https://nutritionmatters.jp/common/pdf/tools/ClinicalHandbookWithPracticeTools_jp.pdf
 
3) 健康長寿ネット https://www.tyojyu.or.jp/net/index.html
 
4) 「静脈経腸栄養ガイドライン 第3版」(日本静脈経腸栄養学会/編), 照林社, 2013
 
5) 宮澤 靖:栄養剤から見たPEG. 静脈経腸栄養, 29:975-980, 2014
 
6) 関根里恵:下痢/便失禁. 臨床栄養, 124:854-860, 2014
Medical*Online
7) 北久保佳織:下痢/便失禁. 臨床栄養, 124:874-878, 2014
Medical*Online
8) 日本臨床内科医会:わかりやすい病気のはなしシリーズ 下痢の正しい対処法, pp8-9, 2010 http://www.japha.jp/doc/byoki/042.pdf
 
P.148 掲載の参考文献
1) 「NST完全ガイド 改版」(東口高志/著), 照林社, 2009
 
2) 日本静脈経腸栄養学会:「静脈経腸栄養ガイドライン 第3版」(日本静脈経腸栄養学会/編), 照林社, 2013
 
3) Abbott:臨床栄養ハンドブック, 2014 https://nutritionmatters.jp/common/pdf/tools/ClinicalHandbookWithPracticeTools_jp.pdf
 
P.150 掲載の参考文献
1) 保木昌得, 他:静脈栄養法-製剤と管理. 薬局 (特集:Q&Aで学ぶ栄養管理と薬学管理), 59(7月臨時増刊号):70-91, 2008
 
2) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会:日本版重症患者の栄養療法ガイドライン. 日集中医誌, 23:185-281, 2016
 
3) McClave SA, et al:Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr, 40:159-211, 2016
 
4) 寺島秀雄:ICU管理が必要な術後栄養管理の実際. 「重症患者の治療の本質は栄養管理にあった!」(真弓俊彦/編), 羊土社, pp175-188, 2014
 
5) 岩谷昭, 他:セラチア感染と輸液投与時の衛生管理. 新潟医会誌 117:469-478, 2003
Medical*Online
6) Sakihama T & Tokuda Y:Use of Peripheral Parenteral Nutrition Solutions as a Risk Factor for Bacillus cereus Peripheral Venous Catheter-Associated Bloodstream Infection at a Japanese Tertiary Care Hospital:a Case-Control Study. Jpn J Infect Dis, 69:531-533, 2016
 
7) 静脈栄養製剤の種類と選択. 「静脈経腸栄養ガイドライン 第3版」(日本静脈経腸栄養学会/編), pp33-46, 照林社, 2013
 
8) 静脈栄養アクセスの管理. 「静脈経腸栄養ガイドライン 第3版」(日本静脈経腸栄養学会/編), pp64-110, 照林社, 2013
 
9) クリティカルケアでの栄養管理. 「ICU/CCUの薬の考え方, 使い方 ver.2」(大野博司/著), pp762-793, 中外医学社, 2016
 
P.152 掲載の参考文献
1) 「静脈経腸栄養ガイドライン 第3版」(日本静脈経腸栄養学会/編), pp284-286 照林社, 2013
 
2) 一ツ松勤, 他:脳卒中急性期重症患者に対する早期経腸免疫栄養の効果. 脳卒中, 39:177-183, 2017
Medical*Online
P.153 掲載の参考文献
1) 「消化器疾患・病態のしくみと栄養サポート」(宮澤靖/著), 日総研, 2017
 
2) Weimann A, et al:ESPEN guideline:Clinical nutrition in surgery. Clin Nutr, 36:623-650, 2017
 
3) ASPEN Board of Directors and the Clinical Guidelines Task Force:Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr, 26:1SA-138SA, 2002 https://onlinelibrary.wiley.com/doi/epdf/10.1177/0148607102026001011
 
4) 長澤孝志, 他:ロイシンの摂食による骨格筋蛋白質分解抑制. 必須アミノ酸研究, 163:11-15, 2002
 
5) 安村敏:科学的根拠に基づいたアルブミン製剤の使用ガイドライン (第2版). 日輸血細胞治療会誌, 64:700-717, 2018
Medical*Online
P.155 掲載の参考文献
1) 「臨床倫理学 第5版」(Jonsen AR, 他/著, 赤林朗/監訳), 新興医学出版社, 2006
 
2) 日本老年医学会:平成23年度厚労省老健局老人保健健康増進等事業 高齢者の摂食嚥下障害に対する人工的な水分・栄養補給法の導入をめぐる意思決定プロセスの整備とガイドライン作成 https://www.jpn-geriat-soc.or.jp/about/pdf/jgsH23roukenjigyoujisseki.pdf
 

第3章 脳卒中回復期・維持期の栄養療法

P.171 掲載の参考文献
1) Yoshimura Y, et al:Prevalence of sarcopenia and its association with activities of daily living and dysphagia in convalescent rehabilitation ward inpatients. Clin Nutr, 37:2022-2028, 2018
PubMed
2) Wakabayashi H & Sakuma K:Rehabilitation nutrition for sarcopenia with disability:a combination of both rehabilitation and nutrition care management. J Cachexia Sarcopenia Muscle, 5:269-277, 2014
PubMed
3) Strakowski MM, et al:Malnutrition in rehabilitation. Am J Phys Med Rehabil, 81:77-78, 2002
PubMed
4) Charlton KE, et al:Older rehabilitation patients are at high risk of malnutrition:evidence from a large Australian database. J Nutr Health Aging, 14:622-628, 2010
PubMed
5) Kaiser MJ, et al:Frequency of malnutrition in older adults:a multinational perspective using the mini nutritional assessment. J Am Geriatr Soc, 58:1734-1738, 2010
PubMed
6) Kaiser MJ, et al:Prospective validation of the modified mini nutritional assessment shortforms in the community, nursing home, and rehabilitation setting. J Am Geriatr Soc, 59:2124-2128, 2011
PubMed
7) Pennington CR:Disease-associated malnutrition in the year 2000. Postgrad Med J, 74:65-71, 1998
PubMed
8) de Ulibarri Perez JI:Clinical undernutrition in 2014;pathogenesis, early diagnosis and consequences;undernutrition and trophopathy. Nutr Hosp, 29:785-796, 2014
PubMed
9) Ignacio de Ulibarri J, et al:CONUT:a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp, 20:38-45, 2005
 
10) 吉村芳弘:21世紀における低栄養の諸問題. 「低栄養対策パーフェクトガイド」(吉村芳弘, 他/編), pp2-9, 医歯薬出版, 2019
 
11) Marshall S, et al:The consequences of malnutrition following discharge from rehabilitation to the community:a systematic review of current evidence in older adults. J Hum Nutr Diet, 27:133-141, 2014
 
12) Visvanathan R, et al:Nutritional screening of older people in a sub-acute care facility in Australia and its relation to discharge outcomes. Age Ageing, 33:260-265, 2004
 
13) Thomas DR, et al:Malnutrition in subacute care. Am J Clin Nutr, 75:308-313, 2002
PubMed
14) Davis JP, et al:Impact of premorbid undernutrition on outcome in stroke patients. Stroke, 35:1930-1934, 2004
PubMed
15) Anker SD, et al:ESPEN Guidelines on Enteral Nutrition:Cardiology and pulmonology. Clin Nutr, 25:311-318, 2006
PubMed
16) Wakabayashi H & Sashika H:Malnutrition is associated with poor rehabilitation outcome in elderly inpatients with hospital-associated deconditioning a prospective cohort study. J Rehabil Med, 46:277-282, 2014
PubMed
17) Fielding RA, et al:Sarcopenia:an undiagnosed condition in older adults. Current consensus definition:prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc, 12:249-256, 2011
 
18) Yaxley A, et al:The complexity of treating wasting in ambulatory rehabilitation:Is it starvation, sarcopenia, cachexia or a combination of these conditions? Asia Pac J Clin Nutr, 21:386-393, 2012
PubMed
19) Sanchez-Rodriguez D, et al:Sarcopenia in post-acute care and rehabilitation of older adults:A review. Eur Geriatr Med, 7:224-231, 2016
 
20) Cruz-Jentoft AJ, et al:Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39:412-423, 2010
 
21) 「サルコペニア診療ガイドライン 2017年度版」(サルコペニア診療ガイドライン作成委員会/編), ライフサイエンス出版, 2017
 
22) Chen LK, et al:Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 15:95-101, 2014
 
23) Nagai S, et al:Relationship between the intensity of stroke rehabilitation and outcome:A survey conducted by the Kaifukuki Rehabilitation Ward Association in Japan (second report). Jpn J Compr Rehabil Sci, 2:77-81, 2011
 
24) Tokunaga M, et al:Relationship between hospital ranking based on Functional Independence Measure (FIM) efficiency and factors related to rehabilitation system for stroke patients - A study of three hospitals participating in Kumamoto Stroke Liaison Critical Pathway. Jpn J Compr Rehabil Sci, 3:51-58, 2012
 
25) Foley NC, et al:A review of the relationship between dysphagia and malnutrition following stroke. J Rehabil Med, 41:707-713, 2009
PubMed
26) Burke DT, et al:Effect of body mass index on stroke rehabilitation. Arch Phys Med Rehabil, 95:1055-1059, 2014
PubMed
27) 酒井友惠:脳卒中. 「リハビリテーション栄養ポケットマニュアル」(日本リハビリテーション栄養学会/監, 若林秀隆/編著), pp210-215, 医歯薬出版, 2018
 
28) 西岡心大, 他:本邦回復期リハビリテーション病棟入棟患者における栄養障害の実態と高齢脳卒中患者における転帰, ADL帰結との関連. 日静脈経腸栄会誌, 30:1145-1151, 2015
 
29) Nii M, et al:Nutritional Improvement and Energy Intake Are Associated with Functional Recovery in Patients after Cerebrovascular Disorders. J Stroke Cerebrovasc Dis, 25:57-62, 2016
PubMed
30) Nishioka S, et al:Nutritional Improvement Correlates with Recovery of Activities of Daily Living among Malnourished Elderly Stroke Patients in the Convalescent Stage:A Cross-Sectional Study. J Acad Nutr Diet, 116:837-843, 2016
 
31) English C, et al:Loss of skeletal muscle mass after stroke:a systematic review. Int J Stroke, 5:395-402, 2010
PubMed
32) Rabadi MH, et al:Intensive nutritional supplements can improve outcomes in stroke rehabilitation. Neurology, 71:1856-1861, 2008
PubMed
33) Ha L, et al:Individual, nutritional support prevents undernutrition, increases muscle strength and improves QoL among elderly at nutritional risk hospitalized for acute stroke:a randomized, controlled trial. Clin Nutr, 29:567-573, 2010
PubMed
34) Geeganage C, et al:Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev, 10:CD000323, 2012
PubMed
35) 吉村芳弘, 他:フレイルと嚥下. Modern Physician (特集:トータルケアをめざしたフレイル診療), 38:496-500, 2018
 
36) Baijens LW, et al:European Society for Swallowing Disorders - European Union Geriatric Medicine Society white paper:oropharyngeal dysphagia as a geriatric syndrome. Clin Interv Aging, 11:1403-1428, 2016
PubMed
37) 吉村芳弘:経腸栄養に用いられる製剤および食品:中鎖脂肪酸. PDNレクチャー http://www.peg.or.jp/lecture/enteral_nutrition/04-07-03.html (2019年10月閲覧)
 
38) 嶋津さゆり, 他:熊リハパワーライス(R)は脳卒中回復期の栄養状態や機能的予後を改善する. 学会誌JSPEN, 1(3), 2019 https://onlinejournal.jspen.or.jp/User/articles/32
 
39) Yoshimura Y, et al:Effects of Nutritional Supplements on Muscle Mass and Activities of Daily Living in Elderly Rehabilitation Patients with Decreased Muscle Mass:A Randomized Controlled Trial. J Nutr Health Aging, 20:185-191, 2016
 
40) Takeuchi I, et al:Effects of branched-chain amino acids and vitamin D supplementation on physical function, muscle mass and strength, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation:A multicenter randomized controlled trial. Geriatr Gerontol Int, 19:12-17, 2019
 
41) 長野文彦, 他:起立着席運動は脳卒中回復期の機能的予後を改善する. 日本サルコペニア・フレイル学会誌, 3(1):92-98, 2019
 
42) Yoshimura Y, et al:Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia:A randomized controlled trial. Nutrition, 58:1-6, 2019
PubMed
P.183 掲載の参考文献
1) Smithard DG, et al:The natural history of dysphagia following a stroke. Dysphagia, 12:188-193, 1997
PubMed
2) 葛谷雅文, 他:要介護高齢者の経口摂取困難の実態ならびに要因に関する研究. 静脈経腸栄養, 26:1265-1270, 2011
 
3) 「平成23年度 老人保健事業推進費等補助金 老人保健健康増進等事業 摂食嚥下障害に係る調査研究事業報告書」(国立長寿医療研究センター), 2012 https://www.ncgg.go.jp/ncgg-kenkyu/documents/roken/cl_hokoku1_23.pdf
 
4) Suzuki Y, et al:Survival of geriatric patients after percutaneous endoscopic gastrostomy in Japan. World J Gastroenterol, 16:5084-5091, 2010
PubMed
5) Kusano C, et al:Current status of percutaneous endoscopic gastrostomy (PEG) in a general hospital in Japan:a cross-sectional study. J Rural Med, 11:7-10, 2016
 
6) Oshima F, et al:Prediction of dysphagia severity:an investigation of the dysphagia patterns in patients with lateral medullary infarction. Intern Med, 52:1325-1331, 2013
PubMed
7) Besson G, et al:Acute pseudobulbar or suprabulbar palsy. Arch Neurol, 48:501-507, 1991
PubMed
8) Fandler S, et al:Dysphagia in supratentorial recent small subcortical infarcts results from bilateral pyramidal tract damage. Int J Stroke, 13:815-819, 2018
PubMed
9) Jeyaseelan RD, et al:National Institutes of Health Stroke Scale (NIHSS) as An Early Predictor of Poststroke Dysphagia. PM R, 7:593-598, 2015
PubMed
10) Broadley S, et al:Predictors of prolonged dysphagia following acute stroke. J Clin Neurosci, 10:300-305, 2003
PubMed
11) Kiphuth IC, et al:Predictive factors for percutaneous endoscopic gastrostomy in patients with spontaneous intracranial hemorrhage. Eur Neurol, 65:32-38, 2011
PubMed
12) Kumar S, et al:Predictors of percutaneous endoscopic gastrostomy tube placement in patients with severe dysphagia from an acute-subacute hemispheric infarction. J Stroke Cerebrovasc Dis, 21:114-120, 2012
PubMed
13) Alshekhlee A, et al:National Institutes of Health stroke scale assists in predicting the need for percutaneous endoscopic gastrostomy tube placement in acute ischemic stroke. J Stroke Cerebrovasc Dis, 19:347-352, 2010
 
14) AVERT Trial Collaboration group:Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT):a randomised controlled trial. Lancet, 386:46-55, 2015
 
15) Dziewas R, et al:Do nasogastric tubes worsen dysphagia in patients with acute stroke? BMC Neurol, 8:28, 2008
PubMed
16) Hilker R, et al:Nosocomial pneumonia after acute stroke:implications for neurological intensive care medicine. Stroke, 34:975-981, 2003
PubMed
17) 高畠英昭:脳卒中患者の口腔ケア自立度とエビデンスに基づく口腔ケア法. 日本クリニカルパス学会誌, 17:358-361, 2015
Medical*Online
18) Takahata H, et al:Early intervention to promote oral feeding in patients with intracerebral hemorrhage:a retrospective cohort study. BMC Neurol, 11:6, 2011
PubMed
19) Crary MA, et al:Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil, 86:1516-1520, 2005
PubMed
Takahata, H:Oral Feeding in Patients with Intracerebral Hemorrhage:Risk versus Benefits. [Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease] (Watson R & Preedy V, eds), pp381-384, Elsevier
 
P.197 掲載の参考文献
1) Rosenberg I:Summary comments:epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr, 50:1231-1233, 1989
 
2) Baumgartner RN, et al:Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol, 147:755-763, 1998
PubMed
3) Cruz-Jentoft AJ, et al:Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39:412-423, 2010
 
4) Chen LK, et al:Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 15:95-101, 2014
 
5) Anker SD, et al:Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle, 7:512-514, 2016
 
6) 「サルコペニア診療ガイドライン 2017年度版」(サルコペニア診療ガイドライン作成委員会/編), ライフサイエンス出版, 2017
 
7) Arai H, et al:Clinical Guidelines for Sarcopenia. Geriatr Gerontol Int, 18 Suppl 1:1-44, 2018
 
8) Cruz-Jentoft AJ, et al:Sarcopenia:revised European consensus on definition and diagnosis. Age Ageing, 48:16-31, 2019
PubMed
9) サルコペニア診断基準の改訂 (AWGS2019発表). 日本サルコペニア・フレイル学会ホームページ http://jssf.umin.jp/pdf/revision_20191111.pdf (2020年1月閲覧)
 
10) 藤原佳典:地域高齢者における社会的フレイルの概念と特徴～社会的側面から見たフレイル～. 日転倒予会誌, 3(3):11-16, 2017
 
11) Malmstrom TK, et al:SARC-F:a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle, 7:28-36, 2016
 
P.206 掲載の参考文献
1) Kawakami M, et al:Resting Energy Expenditure in Patients with Stroke during the Subacute Phases - Relationships with Stroke Types, Location, Severity of Paresis, and Activities of Daily Living. Cerebrovasc Dis, 39:170-175, 2015
PubMed
2) Moore SA, et al:Measuring energy expenditure after stroke:validation of a portable device. Stroke, 43:1660-1662, 2012
PubMed
3) 厚生労働省:「日本人の食事摂取基準 (2020年版)」策定検討会報告書 https://www.mhlw.go.jp/content/10901000/000491509.pdf (2019年9月閲覧)
 
4) 西岡心大:低栄養とリハビリテーション栄養管理の考え方-特にエネルギー必要量に関して-. 日静脈経腸栄会誌, 31:944-948, 2016
 
5) English C, et al:Changes in fat mass in stroke survivors:a systematic review. Int J Stroke, 7:491-498, 2012
PubMed
6) English C, et al:Loss of skeletal muscle mass after stroke:a systematic review. Int J Stroke, 5:395-402, 2010
PubMed
7) Kernan WN, et al:Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45:2160-2236, 2014
PubMed
8) Wright L, et al:Comparison of energy and protein intakes of older people consuming a texture modified diet with a normal hospital diet. J Hum Nutr Diet, 18:213-219, 2005
 
9) 朴成愛, 他:経管栄養管理下の重症心身障害児・者におけるセレン欠乏症の実態-栄養形態による差異と心電図変化. 脳と発達, 34:37-42, 2002
 
10) 日本摂食嚥下リハビリテーション学会医療検討委員会:間歇的口腔食道経管栄養法の標準的手順. 日摂食嚥下リハ会誌, 19:234-238, 2015
 
P.209 掲載の参考文献
1) Nishioka S, et al:Relationship between weight gain, functional recovery and nutrition monitoring in underweight tube-fed stroke patients. Jpn J Compr Rehabil Sci, 9:3-10, 2018
 
P.213 掲載の参考文献
1) 荒木真美子:摂食嚥下障害患者への栄養指導の実際. Nutrition Care, 9:813-827, 2016
Medical*Online
2) Wright L, et al:Comparison of energy and protein intakes of older people consuming a texture modified diet with a normal hospital diet. J Hum Nutr Diet, 18:213-219, 2005
 
3) 西岡心大, 西岡絵美:"食が細くなっているから仕方ない"ではない!摂食栄養量を増加させるための工夫. エキスパートナース, 33(12):29-31, 2017
 
P.215 掲載の参考文献
1) WAM NET(独立行政法人福祉医療機構) https://www.wam.go.jp/content/wamnet/pcpub/kaigo/handbook/service/c078-p02-02-Kaigo-08.html (2019年10月閲覧)
 

書評

最近チェックした商品履歴

Loading...